SCHEMBL6000686

SCHEMBL6000686

[CH2]COCc1occ2ccccc12

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002448 0.79 ALDH1A1 (0.35)
SCHEMBL2090282 0.78 MAPT (0.33) DAO
SCHEMBL6591672 0.76 ALDH1A1 (0.32)
SCHEMBL6002752 0.73 MAPT (0.30)
SCHEMBL2090532 0.71 MAPT (0.33)
SCHEMBL9935525 0.71 TDP1 (0.35) DAO
SCHEMBL2094693 0.71 CYP2A6 (0.35)
SCHEMBL1746782 0.71 MAOB (0.40)
SCHEMBL9739681 0.71 HTR2A (0.43)
SCHEMBL2088776 0.70 MAPT (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed